SCT and StemCells in cross-licensing deal
Deal Date: Aug-01-2006 / Deal # 200620565
Executive Summary
StemCells (cell therapeutics for CNS, liver, and pancreatic diseases) has licensed its neural stem cells to Stem Cell Therapeutics (SCT), which develops pharmaceutical treatments that stimulate endogenous stem cell growth. SCT is simultaneously giving StemCells access to its IP for use in drug discovery, screening, testing, and therapeutic use of cellular compositions.
